Today, shares of Medexus Pharmaceuticals Inc opened at $1.59 and closed at $1.54. Intraday prices ranged from a low of $1.51 to a high of $1.59.

Share prices reduced -1.28% from the previous day's close of $1.56.

During the day across North America, the TSX Composite closed -0.73% at 21740.20, the S&P 500 closed -1.20% at 5061.82, the Dow Jones Industrial Average closed -0.65% at 37735.11 and the Nasdaq Composite closed -1.79% at 15885.02.

Medexus Pharmaceuticals Inc traded under MDP on the Toronto Stock Exchange (TSX).

A total of 26,610 shares was traded during the last trading day, with total trades of 76, with an average volume of 58,089 in the last five days.

Trading across the entire TSX saw 1,840 price advancers against 3,375 declines and 112 unchanged.

During the prior 52 weeks, MDP.TO has traded as high as $3.53 (August 24,2023) and low as $1.12 (June 09,2023). Moreover, the shares have advanced 1.99% in the last 52 weeks, while this year, they have shrunken -37.65%.

Following today's trading, Medexus Pharmaceuticals Inc has a market capitalization of $38.15 million on a float of 24,458 shares outstanding. Its annual EPS is $0.29.

Medexus Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Bolton, CAN.

Medexus Pharmaceuticals Inc is holding an average recommendation of "Moderate Buy" from 4.00 analysts according to Zacks. From those 4 analysts, 4 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..